A 14-week, Multi-center Study of [S,S]-Reboxetine in Patients With Fibromyalgia.
Status:
Completed
Trial end date:
2009-05-01
Target enrollment:
Participant gender:
Summary
This is a study to investigate the effectiveness and safety of [S,S]-Reboxetine in relieving
the symptoms of Fibromyalgia in patients. A previous study demonstrated clinically meaningful
treatment effects in fibromyalgia, based on pain and functional endpoints.